Development

Feliza Mirasol is the science editor for 

Podcasts

A look back at challenge and innovation highlights in 2022 for oral solid dosage forms, this podcast episode will review industry experts’ takes on factors driving the evolution of OSD forms as well as innovations in APIs, technology, and methodology. 

Drug Solutions Podcast: Oral Solid Dosage Forms: A Look Back at Challenges and Innovations

Sam Turner is director of Technology and Development at Capcium.

Naresh Talwar, PhD, is director of Product Development at Capcium.

Ajay Pazhayattil*, M.Pharm, DBA, Ajay.Pazhayattil@capcium.com, is vice-president, Scientific and Regulatory Affairs at Capcium.

Articles

Advancements in soft capsule technology can enable the development of soft capsule formulations, which are becoming the preferred method of oral administration.

Novel Formulations and Line Extensions with Soft Capsule Technology

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

High-concentration injectable formulations present unique challenges.

Excipients for Solubility Enhancement of Parenteral Formulations

Editor of Pharmaceutical Technology Europe

Opportunities and developments in particle engineering are providing developers with the tools to advance drug candidates successfully.

Putting a Spotlight on Particle Engineering

Gerresheimer has developed a new dropper insert for ophthalmic formulations that it is showcasing at CPHI 2022 in Frankfurt, Germany.

Gerresheimer Showcases DropControl, a New Dropper Solution for Ophthalmic Formulations, at CPHI 2022

Aenova Group and Microcaps are partnering to enable new customized formulations for product development and life cycle management solutions.

Aenova and Microcaps Enter Strategic Collaboration

Frédérique Bordes-Picard is vice-president of Business Development, Europe, at Nanoform.

Patient centricity is driving change in drug discovery and development, leading to a a new dawn in therapeutics.

Small is a Powerful Ingredient for Patient-Centric Formulations

Robert O. Williams III, PhD, is the division head and professor of molecular pharmaceutics and drug delivery at The University of Texas at Austin, College of Pharmacy; the Johnson & Johnson centennial chair in pharmacy at the University of Texas at Austin, College of Pharmacy; editor-in-chief of the AAPS PharmSciTech scientific journal; and the technology inventor/special advisor for TFF Pharmaceuticals.

How dry powder techniques can overcome limitations in biologics development and delivery to broaden routes of administration and global accessibility.

Improved Formulations to Enable Stable Delivery of Biologics

Greg Paddon-Jones, PhD, is director of Product Development at Antares Health Products.

The author discusses some new applications of TPGS in the pharmaceutical field that should see this versatile excipient retain its place in the drug formulators toolbox.

Emerging Applications of Vitamin E TPGS in Drug Delivery

Meg Rivers is the former senior editor for 

One company reaches beyond traditionally-conceived male contraceptives with Vasalgel, a reversible hydrogel injectable. 